Evaluation of the Methylation Status of the MEIS۱ Promoter Gene in Colorectal Cancer

Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 48

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MISJ-7-4_005

تاریخ نمایه سازی: 25 آبان 1402

Abstract:

Background: Colorectal cancer, the third most common type of cancer is a major cause of mortality worldwide. If colorectal cancer is detected at the early stages, the ۵-year survival rate is ۹۰%. MEIS۱ homeobox gene is implicated in numerous solid tumors and hematological malignancies. Therefore, the present study aims to investigate the methylation status of the MEIS۱ gene in colorectal cancer.Methods: We used real-time quantitative methylation-specific PCR to detect MEIS۱ promoter methylation in ۴۲ colorectal cancer tissues and ۴۲ normal colorectal tissues.Results: Methylation was observed only in the positive control samples - CG Genome Universal Unmethylated DNA and CG Genome Universal Methylated DNA. There was no change observed in MEIS۱ promoter methylation status in ۴۲ patients.Conclusion: The results of the current study indicated that the MEIS۱ gene promoter was not methylated in the cases. Gene expression study confirmed the unmethylated status of the MEIS۱ gene in the colorectal cancer process among the studied population.

Authors

Narjes Soltani

Cancer Molecular Pathology Research Center, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Ehsan Ghayoor Karimiani

Hope Genetic Polyclinic, Mashhad, Iran

Mohammadreza Farzanehfar

Department of Internal Medicine, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Baratali Mashkani

Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Amirhossein Jafarian

Cancer Molecular Pathology Research Center, Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Hami Ashraf

Razavi Cancer Research Center, Research and Education Department, Razavi Hospital, Mashhad, Iran

Arash Akhavan Rezyat

Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Soukhtanloo

Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran